2 research outputs found
Supplemental Figure S1 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy
In vivo doxycycline administration results in significant TR-APC induction throughout tumors</p
Supplemental Figure S2 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy
In vivo TR-APC induction results in no observable off-target toxicity</p